← Back to ANGO

AngioDynamics, Inc. - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSAug 2026Filed 08/10/2026Feb 2026Filed 02/04/2026Nov 2025Filed 02/04/2026Aug 2025Filed 08/10/2026Feb 2025Filed 02/04/2026Nov 2024Filed 02/04/2026Aug 2024Filed 02/04/2026Feb 2024Filed 02/04/2025
$81$78$79$76$72$73$67$75
−$7.1−$8.1−$6.4−$11−$4.4−$11−$13−$188
−$0.17−$0.19−$0.15−$0.26−$0.11−$0.26−$0.31−$4.67
4242424141414140

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.